Frontotemporal dementia: Impact of P301L tau mutation on a healthy carrier

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 11, 2004, Pages 1607-1610

  Alberici, A ^a   Gobbo, C ^b   Panzacchi, A ^b   Nicosia, F ^a   Ghidoni, R ^a   Benussi, L ^a   Hock, C ^c   Papassotiropoulos, A ^c   Liberini, P ^d   Growdon, J H ^e   Frisoni, G B ^a   Villa, A ^a   Zanetti, O ^a   Cappa, S ^b   Fazio, F ^b,f   Binetti, G ^a  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^d SPEDALI CIVILI   (Italy)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN MAPPING; BRAIN PERFUSION; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; MALE; NEUROIMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL PARAMETRIC MAPPING;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; BRAIN ISCHEMIA; CHILD; DEMENTIA; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; FRONTAL LOBE; HETEROZYGOTE DETECTION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; PEDIGREE; REFERENCE VALUES; TAU PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 7244223202     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.021295     Document Type: Article

References (29)

1. Snowden JS, Neary D, Mann DM. Frontotemporal dementia. Br J Psychiatry 2002;180:140-3.
2. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemparal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-18.
3. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration-a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-54.
4. McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia. Arch Neurol 2001;58:1803-9.
5. Morris HR, Khan MN, Janssen JC, et al. The genetic and pathological classification of familial frontotemporal dementia. Arch Neurol 2001;58:1813-16.
6. Binetti G, Locascio JJ, Corkin S, et al. Differences between Pick disease and Alzheimer disease in clinical appearance and rate of cognitive decline. Arch Neurol 2000;57:225-32.
7. Stevens M, van Duijn CM, Kamphorst W, et al. Familial aggregation in frontotemporal dementia. Neurology 1998;50:1541-545.
8. Hutton M, Lendon C, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with inherited dementia FTDP-17. Nature 1998;393:702-5.
9. Dumanchin C, Camuzat A, Campion D, et al. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Hum Mol Genet 1998;11:1825-9.
10. Houlden H, Baker M, Adamson J, et al. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia. Ann Neurol 1999;46:243-8.
11. Rizzu P, van Swieten JC, Joosse M, et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet 1999;64:414-21.
12. Poorkaj P, Grossman M, Steinbart E, et al. Frequency of tau gene mutations in familial and sporadic cases of non-alzheimer dementia. Arch Neurol 2001;58:383-7.
13. Binetti G, Nicosia F, Benussi L, et al. Prevalence of TAU mutations in an Italian clinical series of familial frontotemporal patients. Neurosci Lett 2003;338:85-7.
14. Binetti G, Magni E, Padovani A, et al. Executive dysfunction in early Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996;60:91-3.
15. Caffarra P, Vezzadini G, Dieci F, et al. Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci 2002;22:443-7.
16. Heaton RK, Chelune GJ, Talley JK, et al. Wisconsin Card Sorting Test, Forma completa revisionata, adattamento italiano a cura di Hardoy MC, Carta MG, Hardoy MJ e Cabras PL, Organizzazioni Speciali, Firenze, 2000:101-8.
17. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. Stuttgart/New York: Georg Thieme Verlag, 1988.
18. Stamatakis EA, Globus MF, Wyper DJ, et al. Validation of statistical parametric mapping (SPM) in assessing cerebral lesions: a simulation study. Neuroimage 1999;10:397-407.
19. Barnes A, Lusman D, Patterson J, et al. The use of statistical parametric mapping (SPM96) as a decision aid in the differential diagnosis of dementia using 99mTc-HMPAO SPECT. Behav Neurol 2000;12:77-86.
20. Vanmechelen E, Vanderstichele H, Davidsson P, et al. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosc Lett 2000;285:49-52.
21. Sjoqren M, Vanderstichele H, Agren H, et al. Tau and Aβ42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem 2001;47:1776-81.
22. Siri S, Benaglio I, Frigerio A, et al. A brief neuropsychological assessment for the differential diagnosis between frontotemporal dementia and Alzheimer's disease. Eur J Neurol 2001;8:125-32.
23. Geschwind DH, Robidoux J, Alarcon M, et al. Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia. Ann Neurol 2001;50:741-6.
24. Kelley WM, Miezin FM, McDermott KB, et al. Hemispheric specialization in human dorsal frontal cortex and medial temporal lobe for verbal and non verbal memory encoding. Neuron 1998;20:927-36.
25. 1-42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging. J Neurol Transm 2000;107:563-79.
26. Riemenschneider M, Wagenpfeil S, Diehl J, et al. Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration. Neurology 2002;58:1585-6.
27. Golde TE, Eckman CB, Younkin SG. Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. Biochim Biophys Acta 2000;1502:172-87.
28. Mann DMA, McDonagh AM, Pickering-Brown SM, et al. Amyloid β protein deposition in patients with frontotemporal lobar degeneration: relationship to age and apolipoprotein E genotype. Neurosci Lett 2001;304:161-4.
29. Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 2001;24:121-59.